Keywords: new, trial/indication, velcade, millennium, pharmaceuticals, started, phase

New trial/indication for Velcade

Article | 20 January 2003

Print This

Millennium Pharmaceuticals has started a Phase II trial of Velcade(bortezomib), currently in a pivotal Phase III trial in multiple ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in